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ABSTRACT
Mitochondria play a central role during neurogenesis by
providing energy in the form of ATP for cytoskeletal
remodelling, outgrowth of neuronal processes, growth
cone activity and synaptic activity. However, the fun-
damental question of how differentiating neurons control
mitochondrial biogenesis remains vastly unexplored. Since
our previous studies have shown that the neurogenic bHLH
(basic helix–loop–helix) transcription factor NeuroD6 is
sufficient to induce differentiation of the neuronal
progenitor-like PC12 cells and that it triggers expression
of mitochondrial-related genes, we investigated whether
NeuroD6 could modulate the mitochondrial biomass using
our PC12-ND6 cellular paradigm. Using a combination of
flow cytometry, confocal microscopy and mitochondrial
fractionation, we demonstrate that NeuroD6 stimulates
maximal mitochondrial mass at the lamellipodia stage, thus
preceding axonal growth. NeuroD6 triggers remodelling of
the actin and microtubule networks in conjunction with
increased expression of the motor protein KIF5B, thus
promoting mitochondrial movement in developing neurites
with accumulation in growth cones. Maintenance of the
NeuroD6-induced mitochondrial mass requires an intact
cytoskeletal network, as its disruption severely reduces
mitochondrial mass. The present study provides the first
evidence that NeuroD6 plays an integrative role in co-
ordinating increase in mitochondrial mass with cytoskeletal
remodelling, suggestive of a role of this transcription factor
as a co-regulator of neuronal differentiation and energy
metabolism.
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INTRODUCTION
Differentiation of progenitor cells into neurons requires
energy in the form of ATP produced in mitochondria via
oxidative phosphorylation for cytoskeletal assembly, axonal
and dendritic growth, growth cone activity and organelle
transport (Bernstein and Bamburg, 2003). Early studies have
shown that developing neurons exhibit a biphasic increase in
total mitochondrial proteins, suggestive of augmented
mitochondrial biogenesis during early neuronal differenti-
ation and maturation corresponding to growth cone
1To whom correspondence should be addressed (email anaaec@gwumc.edu).
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asnneuro.org / Volume 1 (4) / art:e00016 195formation and establishment of the neuronal network with
synaptic activity respectively (Cordeau-Lossouarn et al., 1991;
Vayssiere et al., 1992). Although mitochondrial trafficking
during neuronal differentiation has been well studied
(Hollenbeck and Saxton, 2005; Chan, 2006; Chang and
Reynolds, 2006), little emphasis has been placed on
mitochondrial biogenesis and its transcriptional regulation.
The fact that mitochondrial dysfunctions are often associated
with neurodevelopmental disorders, such as mitochondrial
encephalopathies and axonal Charcot–Marie–Tooth neuro-
pathy (Darin et al., 2001; Zeviani and Di Donato, 2004) raises
the fundamental question of how mitochondrial biogenesis is
controlled in differentiating neuronal cells.
Mitochondrial biogenesis is a complex process, requiring
bi-genomic co-ordination between the nuclear and mito-
chondrial genomes, with more than 95% of the genes being
nuclear-encoded, as the mitochondrial genome encodes a
small number (13) of protein subunits of the respiratory
complexes I, III, IV and V, along with the necessary tRNAs and
rRNAs for their translation (reviewed by Wallace, 2005,
Bonawitz et al., 2006; Scarpulla, 2008). To add to the
complexity, nuclear-encoded genes are expressed in both a
pan- and neural-specific manner, suggesting that mitochon-
dria may also be ‘micro-regulated’ in a neuronal-specific
fashion.
Since most mitochondrial-related transcriptional studies
have been performed within the context of adipocyte and
muscle cell differentiation (Carmona et al., 2002; Wu et al.,
2002; Wilson-Fritch et al., 2003; Handschin et al., 2003; Wu
et al., 2006; Franko et al., 2008), there is a gap in our
knowledge regarding the identity of neuronal-specific
transcription factors regulating mitochondrial biogenesis in
response to energy needs during neurogenesis. Thus far, only
PGC-1a (peroxisome-proliferator-activated receptor-c co-
activator 1a), the original member of the PGC-1 family of
transcriptional co-activators, has been well established as a
master regulator of mitochondrial biogenesis in adipocyte
and muscle cell differentiation (Puigserver et al., 1998; Wu
et al., 1999; Lehman et al., 2000). It functions as an integrator
of physiological and environmental cues to implement a
specific transcriptional programme, of which NRF (nuclear
respiratory factor)-1 and -2 are key transcriptional regulators
co-ordinating expression of several nuclear-encoded subunits
of the respiratory complexes and mitochondrial transcription
factors (reviewed by Scarpulla, 2008). It is only recently that
the expression and activity of NRF-1 and -2 have been
correlated with activity of visual cortical neurons (Liang et al.,
2006; Yang et al., 2006; Dhar et al., 2008; Dhar and Wong-
Riley, 2009).
Therefore the question of whether neurogenic transcrip-
tion factors are capable of stimulating mitochondrial
biogenesis directly while executing terminal neuronal differ-
entiation of progenitor cells remains largely unexplored.
Members of the bHLH (basic helix–loop–helix) NeuroD family
are potential candidates, being key transcriptional regulators
of terminal differentiation during neurogenesis (Guillemot,
2007), at a time when increase in total mitochondrial proteins
was observed (Cordeau-Lossouarn et al., 1991). We focused
on NeuroD6 (Nex1/MATH-2) whose expression is triggered at
E11 (where E is embryonic day), coinciding with neuronal
progenitor cells undergoing cell-cycle arrest and terminal
differentiation, and further peaks during the first postnatal
week, when neuritogenesis and synaptogenesis are highly
active (Schwab et al., 1998, 2000; Schuurmans et al., 2004).
Our in vitro functional studies have shown that NeuroD6 by
itself initiates and executes differentiation of neuronal-like
progenitor PC12 cells, through several interconnected but
distinct transcriptional programmes linking neuritogenesis,
cell-cycle withdrawal and neuronal survival via the mito-
chondrial pathway (Uittenbogaard and Chiaramello, 2002,
2004, 2005). Using a genome-wide microarray approach,
we found that overexpression of NeuroD6 resulted in a
co-ordinated increase in the expression of cytoskeletal
elements and mitochondrial-related genes (Uittenbogaard
et al., 2009).
The goal of the present study was to investigate whether
NeuroD6 could induce and co-ordinate mitochondrial mass
with neuronal differentiation using our PC12-ND6 cellular
paradigm, which constitutively overexpresses NeuroD6 at
levels comparable with that of NGF (nerve growth factor)
exposure (Uittenbogaard and Chiaramello, 2002). Using a
combination of flow cytometry, confocal microscopy and
mitochondrial fractionation, we found that NeuroD6 induced
maximal increase of mitochondrial mass at the very first
stage of neuronal differentiation, the lamellipodia stage.
NeuroD6 also increased expression of the motor protein
KIF5B, while generating a permissive gradient of micro-
tubule-associated proteins for proper mitochondrial move-
ment in developing neurites with accumulation in the growth
cones. Finally, maintenance of the NeuroD6-induced mito-
chondrial mass required an intact cytoskeletal network, as its
disruption severely reduced mitochondrial mass. Collectively,
the present study provides the first evidence that NeuroD6
plays an integrative role in co-ordinating increase in
mitochondrial mass with cytoskeletal remodelling in the very
early stages of neuronal differentiation, suggestive of a
potential role as a co-regulator of neuronal differentiation
and energy metabolism.
MATERIALS AND METHODS
Cell culture and pharmacological treatments
Rat pheochromocytoma PC12 cells and PC12-ND6 cells
(previously called PC12-Nex1, medium-expressing clones)
were grown on collagen I-coated plates (Becton Dickinson
Labware) as described by Uittenbogaard and Chiaramello
(2002). When indicated, cells were differentiated in the
presence of NGF (100 ng/ml) (Roche Molecular Biochemicals).
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coated coverslips. To disrupt microtubules or actin polymer-
ization, PC12-ND6 cells were grown for a period of 10 h in
the presence of 10 mg/ml nocodazole (Sigma) diluted from a
0.4 mg/ml stock in DMSO or 15 mM latrunculin B diluted from
a 5.0 mM stock in DMSO. Control cells were cultured in the
presence of 2.5% DMSO. For the recovery period, DMSO or
drug-containing medium was removed by washing the cells
three times with drug-free medium.
Flow cytometry
Cells were grown on collagen I-coated plates to 80%
confluence before staining with either 50 nM MTR
(MitoTrackerH Red) (chloromethyl-X-rosamine; Molecular
Probes) or 70 nM MTG (MitoTrackerH Green) (Molecular
Probes), for 30 min at 37˚C. Cells were then washed in PBS,
trypsizined, collected by centrifugation at 228 g for 5 min, and
analysed with a FACScalibur flow cytometer (BD Bioscience).
Data were collected from 20000 cells for each sample and
analysed using the CellQuant software (BD Biosciences).
Immunocytochemistry and confocal microscopy
For immunocytochemistry labelling, cells were seeded on to
PDL-coated coverslips. Mitochondria and plasma membrane
were labelled by incubating cells in the presence of 500 nM
MTR and 1.0 mM Alexa FluorH 488-conjugated WGA (wheat
germ agglutinin) (Molecular Probes) diluted in growth
medium for 10 min at 37˚C. All samples were fixed in 4.0%
(w/v) paraformaldehyde for 5 min and permeabilized in 0.2%
Triton X-100 for 5 min. To label polymerized actin filaments,
cells were incubated with Alexa FluorH 488–phalloidin diluted
to a final concentration of 82.5 nM in PBS for 20 min at room
temperature (25˚C) following fixation and permeabilization.
Cells were blocked in 10% goat serum (Invitrogen) for 1 h at
room temperature. All primary and secondary antibody
incubations were performed at room temperature as follows:
1 h of incubation with diluted primary antibodies, followed
by 1 h of incubation with the appropriate diluted Alexa
FluorH-conjugated secondary antibodies (Table 1). When
indicated, cells were incubated with the nuclear counterstain
TO-PROH-3 (Molecular Probes) diluted 1:500 in PBS for 15
min at room temperature. All samples were mounted with
Fluoromount G (Electron Microscopy Sciences). Images were
acquired using a Zeiss LSM 510 confocal system equipped
with a 636 Plan-ApochromatH (numerical aperture 1.4)
objective and Zen software.
Live-cell imaging
PC12 and PC12-ND6 cells were grown on PDL-coated glass-
bottom dishes (Warner Instruments), labelled with 100 nM
MTR for 1 h at 37˚C and imaged in MTR-free medium. Cells
were visualized with an oil-immersion objective 636 on a
Zeiss LSM 510 confocal microscope equipped with a
TempModuleS and CO2 Module (Zeiss) to maintain the
temperature and CO2 levels at 37˚C and 5.0%.
Measurement of mitochondrial area
The mitochondrial area was measured using the histogram
function of the Image J software (http://rsb.info.nih.gov/ij/)
by setting a threshold value excluding 95% of the
background staining, as determined by the pixel values from
the nuclear area (Liang et al., 2007). To delineate the
cytoplasm, we used either the combination of Alexa FluorH
488-conjugated WGA and TO-PROH-3 staining or the
phalloidin and b-III-tubulin labelling.
ATP bioluminescence assay
ATP content was assessed by the luciferin/luciferase-based
CellTiter-Glo
TM luminescent assay (Promega). Briefly, PC12
and PC12-ND6 cells were grown in triplicate in white
opaque-walled 96-well collagen I-coated plates (Becton
Dickinson) at a density of 2.5610
4 cells/well, and 100 mlo f
the CellTiter-GloH reagent was added to each well. Cells were
lysed and incubated for 10 min at room temperature. An ATP
standard curve was generated to calculate the amount in
fmol of ATP per cell. Chemiluminescence was quantified in
triplicate from three independent experiments using the
LMax microplate luminometer (Molecular Devices).
Immunoblot analysis
Whole-cell extracts from PC12 and PC12-ND6 cells were
prepared as described by Uittenbogaard et al. (2009). Proteins
(40 mg) were resolved on a 10% NuPAGE Bis-Tris gel
(Invitrogen) and transferred on to a nitrocellulose membrane,
which was probed with specific antibodies (Table 1) and
corresponding secondary horseradish peroxidase-conjugated
antibodies (Pierce). The antigen–antibody complex was
detected using the Supersignal West Pico Chemiluminescent
Substrate kit (Pierce). Blots were then stripped using Restore
TM
Western blot stripping buffer (Pierce) and re-probed with the
anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase)
antibody to confirm equal protein loading.
Mitochondrial fractionation
Mitochondria-enriched fractions were isolated using a
mitochondrial/cytosol fractionation kit (Sigma) according to
the manufacturer’s instructions. PC12 and PC12-ND6 cells
were grown to 90% confluence and counted using a
haematocytometer. Cells were trypsinized, centrifuged at
600 g for 5 min, washed twice with PBS and resuspended in
an extraction buffer in the presence of protease inhibitors.
Cells were gently homogenized using a Dounce homogenizer,
and the degree of homogenization was visualized by Trypan
Blue staining. The homogenate was centrifuged at 1000 g for
10 min at 4˚C. The supernatant was centrifuged again at 3500
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197g for 10 min at 4˚C, and the pelleted mitochondria were lysed
in the lysis buffer provided in the presence of protease
inhibitors. Protein concentration was determined using the
Bradford assay (Bio-Rad Laboratories).
Statistical analysis
Statistical analyses were performed using the unpaired
Student’s t test, and results are expressed as means¡S.D.
RESULTS
PC12-ND6 cells recapitulate the early stages of
neuronal differentiation
We initially confirmed that PC12-ND6 cells recapitulated the
early stages of neuronal differentiation, as defined by Dotti et
al. (1988). The first three stages of neuronal differentiation,
with stage I being defined as the lamellipodia stage, stage II
as outgrowth of neuritic process, and stage III as axonal
outgrowth, occur very rapidly within 36 h of in vitro culture,
while stage IV, during which dendritic growth is triggered,
begins 2–3 days later, with their subsequent maturation
(stage V) occurring beyond 1 week of culture.
Untreated PC12 and PC12-ND6 cells were labelled with the
fluorescent F-actin (filamentous actin) marker, Alexa FluorH
488–phalloidin and the nuclear counterstain TO-PROH-3, and
analysed by confocal fluorescence microscopy. PC12-ND6
cells spontaneously recapitulated the first four stages of
neuronal differentiation within the first 48 h after plating on
coverglass in the absence of NGF (Figure 1A), with 44% at
stage I, 28 and 25% at stages II and III respectively, and 3% at
stage IV (Figure 1B). By day 9, most of the PC12-ND6 cells
reached stage III/IV, when left unperturbed. As expected,
untreated PC12 cells, which do not express endogenous
NeuroD6, displayed a morphology characteristic of progenitor-
like neuronal cells, small size without an extensive lamellipo-
dium, as observed with stage I PC12-ND6 cells (Figure 1A).
Thus the PC12-ND6 cell system provides an unlimited supply
of differentiating neuronal cells, making it a suitable and
instructive paradigm to investigate NeuroD6’s effect on
mitochondrial mass throughout neuronal differentiation.
NeuroD6 increases mitochondrial mass in PC12-
ND6 cells in a manner similar to that of NGF
treatment
On the basis of the correlation between NeuroD6 and
mitochondrial-related gene expression highlighted by our
genome-wide microarray study (Uittenbogaard et al., 2009),
we hypothesized that NeuroD6 could stimulate mitochondrial
mass. We assessed mitochondrial mass by flow cytometry
using PC12 and PC12-ND6 cells stained with MTG or MTR.
Fluorescence intensity emitted by MTG has been used as an
estimate of overall mitochondrial mass, as it accumulates in
the lipid compartment of the mitochondria in an MMP
(mitochondrial membrane potential)-independent manner,
whereas fluorescence intensity emitted by MTR assesses the
content of energized mitochondria, as its accumulation and
retention has been shown to be MMP-dependent
(Pendergrass et al., 2004). Quantitative flow cytometry
revealed that PC12-ND6 cells displayed 1.8-fold increased
fluorescence emission of each dye, compared with control
PC12 cells (Figure 2A), indicative of increased mitochondrial
mass upon NeuroD6 expression.
Table 1 List of antibodies used for the immunofluorescence studies and immunoblot analyses
IB, immunoblot analysis; ICC, immunocytochemistry; mAb, monoclonal antibody; pAb, polyclonal antibody.
Antibody Type Source (catalogue number) Dilution Application
Zyxin Mouse mAb Abcam (ab50391) 1:500 IB, ICC
Gelsolin Mouse mAb BD Bioscience (610412) 1:200 IB, ICC
MAP-1A Mouse mAb Chemicon (MAB362) 1:500 ICC
MAP-2 Mouse mAb Chemicon (MAB364) 1:250 ICC
Total tau Mouse mAb Millipore (MAB361) 1:500 ICC
Unphosphorylated tau Mouse mAb Chemicon (MAB3420) 1:200 ICC
KIF5B Mouse mAb Abcam (ab28060) 1:100 IB, ICC
Neurofilament M Rabbit pAb Chemicon (AB1987) 1:200 IB, ICC
b-III-tubulin Mouse mAb Convance (MMS-435P) 1:500 ICC
b-III-tubulin Rabbit pAb Abcam (ab18207) 1:500 ICC
SOD2 Rabbit pAb Abcam (ab13534) 1:500 ICC
COX III Mouse mAb MitoSciences (MS304) 1:1000 ICC, IB
KIF5B Mouse mAb Abcam (ab28060) 1:100 ICC, IB
GAPDH Mouse mAb Aplied Biosystems 1:2000 IB
Actin Mouse mAb Chemicon (MAB15010) 1:2000 IB
Alexa FluorH 488-conjugated anti-rabbit IgG Goat pAb Invitrogen (A11034) 1:1000 ICC
Alexa FluorH 488-conjugated anti-mouse IgG Goat pAb Invitrogen (A11029) 1:1000 ICC
Alexa FluorH 488-conjugated anti-goat IgG Donkey pAb Invitrogen (A11055) 1:1000 ICC
Alexa FluorH 568-conjugated anti-rabbit IgG Goat pAb Invitrogen (A11036) 1:1000 ICC
Alexa FluorH 568-conjugated anti-mouse IgG Goat pAb Invitrogen(A11031) 1:1000 ICC
Alexa FluorH 647-conjugated anti-rabbit IgG Goat pAb Invitrogen (A21245) 1:1000 ICC
Alexa FluorH 647-conjugated anti-mouse IgG Goat pAb Invitrogen (A21236) 1:1000 ICC
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(Uittenbogaard and Chiaramello, 2002), we asked whether
NeuroD6 could mimic NGF treatment in terms of mitochon-
drial mass. PC12 and PC12-ND6 cells were differentiated for 2
days with NGF and stained with MTG for flow cytometry
analysis. Although NGF-treated PC12 cells displayed a 1.4-
fold increase in mitochondrial mass, NGF-treated PC12-ND6
cells failed to show any further increase in mitochondrial
mass (Figure 2B), despite their more advanced degree of
differentiation with a preponderance of stages III and IV
(Uittenbogaard and Chiaramello, 2002). In contrast, most
NGF-treated PC12 cells were differentiated at stages I and II
(Uittenbogaard and Chiaramello, 2002). Interestingly,
untreated PC12-ND6 cells exhibited a moderate but consist-
ent increase in mitochondrial mass, compared with NGF-
treated PC12 cells (Figure 2B). Collectively, these results
suggest that increase in mitochondrial mass may occur in the
very early stages of neuronal differentiation and precede
axonal growth.
PC12-ND6 cells display maximal mitochondrial
area at the lamellipodia stage of neuronal
differentiation
Since mitochondrial area is another reliable indicator of
mitochondrial content, similar to mitochondrial mass
(Berman et al., 2009), we measured mitochondrial area by
confocal fluorescence microscopy using PC12 and PC12-ND6
cells labelled with the plasma membrane marker, Alexa FluorH
488-conjugated WGA, the mitochondrial dye MTR, and the
nuclear counterstain TO-PROH-3 (Figure 3A). We confirmed
that MTR labelled the entire population of mitochondria by
co-staining cells with MTR and an antibody against the
mitochondrial enzyme SOD2 (superoxide dismutase 2), an
antioxidant protein known to localize exclusively in the
mitochondrial matrix (see Supplementary Figure S1 at http://
asnneuro.org/an/001/an001e016.add.htm).
Overexpression of NeuroD6 led not only to increased
mitochondrial area, but also to differential distribution of
mitochondria, when compared with control PC12 cells
(Figure 3A). In PC12 cells, mitochondria were localized within
the perinuclear region, whereas mitochondria in stage II
PC12-ND6 cells were positioned in a row to migrate toward
the neuritic tip (Figure 3A, middle row, white arrows).
Similarly, in stage III PC12-ND6 cells, mitochondria were
present throughout the developing neuronal process and
accumulated in the growth cone (Figure 3A, bottom row,
white arrows). During the course of this analysis, we also
assessed mitochondrial morphology using fixed and live PC12
and PC12-ND6 cells stained with SOD2 and MTR respectively
(see Supplementary Figure S2 at http://asnneuro.org/an/001/
an001e016.add.htm). Mitochondria from control PC12 cells
displayed a predominant short and punctate morphology
(arrowheads), whereas stage I PC12-ND6 cells harboured a
heterogeneous mixture of elongated tubular (arrows) and
short (arrowheads) forms of mitochondria. In contrast, the
majority of mitochondria in dividing stage I PC12-ND6 cells
displayed a homogeneous short morphology. In stage III
PC12-ND6 cells, mitochondria morphology varied depending
on their subcellular localization: elongated in the soma, and
short in the growth cones.
Figure 1 PC12-ND6 cells recapitulate the first four stages of neuronal differentiation
(A) Morphological characteristics of PC12-ND6 cells. Untreated PC12 and PC12-ND6 (referred to as ND6) cells were labelled with the
F-actin marker Alexa Fluor 488H–phalloidin (green), anti-b-III-tubulin antibody (red) and the nuclear marker TO-PROH-3 (blue) and
analysed by confocal microscopy. Scale bar, 10 mm. (B) Quantification of the distinct neuronal differentiation stages in cultured
PC12-ND6 cells labelled with phalloidin 48 h after seeding. Results are means¡S.D. for three independent experiments, with n5200
cells per experiment.
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199To quantify the mitochondrial area, the plasma membrane
and nuclear stains were used to delineate the cytoplasm,
while the mitochondrial area labelled with MTR was measured
for each cell type using the Image J software. Since the
results from flow cytometry were suggestive of increased
mitochondrial mass during the early stages of neuronal
differentiation, we quantified the mitochondrial area at each
stage of neuronal differentiation (I–III) for PC12-ND6 cells.
We observed a 3.6-fold increase in mitochondrial area
(P,0.0001) upon NeuroD6 expression at the very first stage
of neuronal differentiation, the lamellipodia stage, when
compared with PC12 cells (Figure 3B). We found no
statistically significant difference in the mitochondrial area
of PC12-ND6 cells throughout stages I–III, consistent with
the flow cytometry analysis. The timing of increased
mitochondrial compartment during neuronal differentiation
was confirmed further by quantifying the mitochondrial area
at distinct stages of NGF-differentiated PC12 cells for 48 h,
stained with an antibody against the core 2 protein of COX
(cytochrome c oxidase) III instead of MTR (Figures 3C and 3D)
to avoid any potential problems of MMP heterogeneity, as
NGF signalling is known to modulate MMP (Verburg and
Hollenbeck, 2008). Taken together, these results reveal that
NeuroD6 triggers an increase in mitochondrial mass in a
manner similar to that of NGF signalling, which essentially
occurs during the transition from undifferentiated neuronal
progenitor-like PC12 cells to stage I differentiating PC12-
ND6 cells.
Overexpression of NeuroD6 results in increased
total mitochondrial proteins and ATP levels
To confirm NeuroD6-increased mitochondrial mass, we
isolated mitochondrial-enriched fractions from PC12 and
PC12-ND6 cells and expressed the protein content of
mitochondrial fractions as percent of total protein content
of the corresponding whole-cell extract (Figure 4A). Total
mitochondrial protein content increased 3.88-fold upon
NeuroD6 expression, in keeping with the 3.6-fold increase
in mitochondrial area measured by confocal microscopy
(Figure 3B).
We next measured total ATP levels from PC12 and PC12-
ND6 cells, as described in the Materials and methods section,
and found 1.56-fold increased ATP levels upon NeuroD6
overexpression (Figure 4B), which paralleled the 1.8-fold
increase in mitochondrial mass measured by flow cytometry
Figure 2 NeuroD6 overexpression results in increased mitochondrial mass in a manner similar to that of NGF treatment
(A) Quantification of the fluorescence intensity of PC12 and PC12-ND6 labelled with mitochondria-specific dyes. Untreated control
PC12 and untreated PC12-ND6 (ND6) cells were stained with MTG or MTR and analysed by flow cytometry. Flow cytometric profiles
of PC12 and PC12-ND6 labelled with mitochondria-specific dyes (left-hand panel). Results are expressed as means¡S.D. for five
independent experiments (right-hand panel). *P,0.05, **P,0.0001 (Student’s t test), compared with control PC12 cells. (B)
Quantification of the fluorescence intensity of MTG-labelled untreated and NGF-treated PC12 and PC12-ND6 cells. Untreated and
NGF-treated (100 ng/ml, 48 h) PC12 and PC12-ND6 cells were stained with MTG and analysed by flow cytometry. Flow cytometric
profiles of PC12 and PC12-ND6 cells grown in the presence or absence of NGF (left-hand panel). Results are expressed as
means¡S.D. for five independent experiments (right-hand panel). *P,0.05 compared with untreated PC12 cells; **P,0.0001
compared with untreated PC12 cells; {P,0.05 compared with PC12 cells treated with NGF for 48 h.
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subunit of the ATP synthase complex (Uittenbogaard and
Chiaramello, 2004), which is essential for its assembly, being
part of the stalk connecting the F1 and Fo moieties (Capaldi et
al., 1994; Zhang et al., 1995). Collectively, these data strongly
suggest that NeuroD6 overexpression results in increased
mitochondrial content and ATP levels.
NeuroD6 promotes rearrangement of actin in
conjunction with the actin regulatory proteins,
zyxin and gelsolin
Actin remodelling plays a critical role in localized and
retrograde movement of mitochondria within axons (Morris
and Hollenbeck, 1995; Ligon and Steward, 2000a; Chada and
Hollenbeck, 2004). The fact that phalloidin labelling revealed
differential distribution of the actin cytoskeleton at distinct
neuronal stages of PC12-ND6 cells (Figure 1A) combined with
5.4- and 2.3-fold increased mRNA levels of the actin-
remodelling proteins zyxin and gelsolin respectively
(Uittenbogaard et al., 2009) prompted us to assess the
spatio-temporal co-localization of actin, zyxin and gelsolin in
PC12-ND6 cells at distinct stages of neuronal differentiation
using confocal microscopy. We initially confirmed increased
zyxin and gelsolin expression at the protein level by
immunoblot analysis (Figure 5A), with zyxin migrating as a
doublet, consistent with its identity as a phosphoprotein
(Crawford and Beckerle, 1991).
Zyxin co-localized with actin in clusters at the leading edge
of the lamellipodia and focal adhesions of stage I PC12-ND6
cells and in the growth cones of stage III PC12-ND6 cells
(Figure 5B, white arrows), consistent with its known ability
to direct cytoskeletal reorganization at the leading edge of
the lamellipodium and growth cones (Beckerle, 1986, 1997;
Figure 3 PC12-ND6 cells display increased mitochondrial area
(A) Staining of the mitochondrial compartment. PC12 and PC12-ND6 cells were stained with MTR (red) and the plasma membrane
marker Alexa FluorH 488-conjugated WGA (green) and TO-PROH-3 (blue). White arrows indicate the presence of mitochondria within
neurites or growth cones (gc). Scale bar, 10 mm. (B) Quantification of mitochondrial area in PC12 and PC12-ND6 cells at different
stages of neuronal differentiation. Results are means¡S.D. for three independent experiments, with a minimum of n5150 cells for
each cell type and a minimum of n550 cells per stage. **P,0.0001 (Student’s t test). (C) Staining of the mitochondrial compartment
in untreated and NGF-differentiated PC12 cells. Untreated and NGF-treated PC12 cells for 48 h (100 mg/ml) were stained with
antibodies against b-III-tubulin (red), COX III (green) and subsequently counterstained with the TO-PROH-3 (blue). Scale bar, 10 mm.
(D) Quantification of mitochondrial area in untreated and NGF-treated PC12 cells. Results are means¡S.D. for three independent
experiments, with n5150 cells per stage. **P,0.0001 (Student’s t test).
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201Crawford and Beckerle, 1991; Drees et al., 1999). Gelsolin co-
localized with actin filaments in growing neurites of stage II
PC12-ND6 cells with enrichment at the tip, whereas PC12-
ND6 cells with stage III morphology exhibit concentrated
expression of gelsolin in the growth cones where it is
expressed in the central domain as well as the leading edge of
the lamellipodia and filopodia (Figure 5C). These results
indicate that NeuroD6 promotes actin remodelling by
simultaneously increasing the expression levels of key
actin-remodelling proteins and promoting their appropriate
spatio-temporal regulation.
NeuroD6 promotes rearrangement of
microtubules and microtubule-binding proteins
We next focused on the microtubule network, as it plays a
critical role in long distance trafficking of mitochondria in
the developing axon toward the growth cone (Morris and
Hollenbeck 1993, 1995; Hollenbeck 1996; Ruthel and
Hollenbeck, 2003). The fact that NeuroD6 increases the
expression of b-III-tubulin protein in the absence of NGF
(Uittenbogaard and Chiaramello, 2004), and promotes its
spatial redistribution throughout the early stages of neuronal
differentiation (Figure 1A), enhances further its potential
contribution to co-ordinate an increase in mitochondrial
mass with movement. On the basis that a proper gradient of
MAPs (microtubule-associated proteins) is critical for mito-
chondrial movement in developing axons (Ebneth et al., 1998;
Trinczek et al., 1999; Seitz et al., 2002; Mandelkow et al.,
2003; Jimenez-Mateos et al., 2006; Dixit et al., 2008), we
assessed the expression pattern of MAP-1A, MAP-2 and Tau
in PC12-ND6 cells at different stages of neuronal differenti-
ation, all of them being up-regulated by NeuroD6
(Uittenbogaard and Chiaramello, 2004). Stage II PC12-ND6
cells displayed equal distribution of MAP-1A among all
growing neurites, whereas stage III PC12-ND6 cells showed
that MAP-1A expression was excluded from the distal portion
of nascent axons (Figure 6A). In contrast, decreased MAP-2
expression was observed in developing axons of stage III
PC12-ND6 cells, with a drastic reduction at their distal
portions (Figure 6B). Thus constitutive NeuroD6 expression
led to proper redistribution of MAP-1A and MAP-2 at distinct
stages of neuronal differentiation, as observed in cultured
embryonic hippocampal neurons (Ca ˜ceres et al., 1986; Dotti
et al., 1988; Pennypacker et al., 1991; Ulloa et al., 1994; Dı ´ez-
Guerra and Avila, 1995).
We next examined the distribution pattern of the unpho-
sphorylated and phosphorylated forms of tau, since their
gradients of expression influence microtubule organization
and mitochondrial movement during axonal outgrowth
(Ca ˜ceres and Kosik, 1990; Ca ˜ceres et al., 1991; Dixit et al.,
2008). We used two distinct anti-tau antibodies, one specific
for the unphosphorylated tau form (at the Tau-1 epitope) and
the other one raised against total tau, to perform
immunocytochemistry on PC12-ND6 cells at different stages
of differentiation. Unphosphorylated tau was evenly dis-
tributed among growing neurites of stage II PC12-ND6 cells,
whereas unphosphorylated tau was enriched in the distal
portion of the developing axon of stage III PC12-ND6 cells
(Figure 6C). Such a proximo-distal gradient was maintained
in stage IV PC12-ND6 cells (data not shown). In contrast, total
tau was evenly distributed in growing processes of PC12-ND6
cells at all stages (Figure 6D). These results are consistent
with the tau expression pattern observed in cultured
embryonic hippocampal neurons (Mandell and Banker,
1996). Taken together, our results indicate that PC12-ND6
cells recapitulate the spatial and temporal expression patterns
of key players compatible with cytoskeletal rearrange-
ment and mitochondrial trafficking during early neuronal
differentiation.
Figure 4 Overexpression of NeuroD6 increases the mitochondrial protein content and cellular ATP levels
(A) Measurement of mitochondrial protein content in PC12 and PC12-ND6 cells. Mitochondrial-enriched fractions were isolated from
PC12 and PC12-ND6 cells grown in the absence of NGF, and the protein content of mitochondrial fractions was expressed as
percentage of total protein content of the corresponding whole-cell extract. Results are means¡S.D. for three independent
experiments. *P,0.001 (Student’s t test). (B) Determination of cellular ATP levels. ATP levels were measured in triplicate from PC12
and PC12-ND6 cells grown in the absence of NGF using the CellTiter-Glo
TM assay. Results are means¡S.D. for three independent
experiments. *P,0.001 (Student’s t test).
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and microtubule-based motor protein KIF5B in
PC12-ND6 cells
Since proper transport and intracellular distribution of
mitochondria are vital for proper neuronal differentiation
to insure high metabolic demands associated with active
growth cones and branching points (Povlishock, 1976; Morris
and Hollenbeck, 1993; Ruthel and Hollenbeck, 2003), we
examined using confocal microscopy the spatio-temporal
expression pattern of the motor protein KIF5B (also called
kinesin-1 heavy chain, KHC) at distinct stages of neuronal
differentiation of untreated PC12-ND6 cells. KIF5B, a member
of the kinesin superfamily, is an essential microtubule-based
motor protein for anterograde mitochondrial transport, as a
body of studies has shown that inhibition of KIF5B, targeted
disruption of kif5b or mutations of the Milton and Miro
proteins necessary to mediate linkage of KIF5B to mitochon-
dria drastically reduce anterograde mitochondrial transport
(Nangaku et al., 1994; Hollenbeck, 1996; Hurd and Saxton,
1996; Hurd et al., 1996; Pereira et al., 1997; Tanaka et al.,
1998; Goldstein and Yang, 2000; Stowers et al., 2002; Go ´rska-
Andrzejak et al., 2003; Hollenbeck and Saxton, 2005; Glater
et al., 2006; Pilling et al., 2006).
Figure 7 clearly illustrates a spatio-temporal pattern of
KIF5B expression compatible with its function in mitochon-
drial transport and subcellular distribution associated with
distinct stages of neuronal differentiation. Stage II PC12-ND6
Figure 5 Reorganization of actin and the actin-binding proteins zyxin and gelsolin
(A) Immunoblot analysis of actin, gelsolin and zyxin proteins in PC12 and PC12-ND6 cells. Immunoblot analysis was performed using
whole-cell extracts from PC12 and PC12-ND6 cells using antibodies against gelsolin, zyxin and actin. Equal loading of protein was
verified using an anti-GAPDH antibody. Results shown are representative of at least three independent experiments. (B) Stage-
specific rearrangement of zyxin. PC12-ND6 cells were labelled with Alexa FluorH 488–phalloidin (green), anti-zyxin antibody (red)
and TO-PROH-3 (blue). Stage I PC12-ND6 cells (top row) display accumulation of zyxin labelling at the focal adhesion points of the
lamellipodium (arrows). In stage III PC12-ND6 cells (bottom row), zyxin labelling has been redistributed to the growth cone (gc,
arrow). Scale bar, 10 mm. In the right-hand panel, a high magnification of the growth cone is shown. Scale bar, 5 mm. (C) Stage-
specific rearrangement of gelsolin. PC12-ND6 cells were labelled with Alexa FluorH 488–phalloidin (green), anti-gelsolin antibody
(red) and TO-PROH-3 (blue). In stage I PC12-ND6 cells (top row), gelsolin labelling is predominantly found at the edge of the
lamellipodium. In stage III PC12-ND6 cells (bottom row), a portion of the gelsolin labelling is found within the growth cone (gc,
arrow). Scale bar, 10 mm. In the right-hand panel, a high magnification of the growth cone is shown. Scale bar, 5 mm.
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203cells displayed a uniform distribution of KIF5B throughout
the cell body and growing neurites with an overlapping
expression pattern with MTR and b-III-tubulin, and enriched
KIF5B expression at the tip of growing neurites with high
density of mitochondria (Figure 7A). During the early phase
of stage II–III transition (referred to as immature stage III),
KIF5B immunoreactivity remained enriched in growth cones,
when compared with the soma (Figure 7A). However, stage III
PC12-ND6 cells no longer displayed such enrichment of KIF5B
(Figure 7A). High magnification revealed a differential spatial
distribution of KIF5B protein in the growth cones depending
on the degree of differentiation of stage III PC12-ND6 cells,
with accumulation of KIF5B in the central domain of growth
cones of immature stage III PC12-ND6 cells and dispersion of
KIF5B protein at the leading edge of growth cones of mature
stage III PC12-ND6 cells (Figure 7B), which is in keeping with
the well-documented interactions between KIF5B and axonal
synaptic vesicles (Cai et al., 2007; Cai and Sheng, 2009).
Finally, stage IV PC12-ND6 cells showed a uniform
distribution of KIF5B in the soma, axon and dendrites, with
the exception of future branching points and axonal growth
cones, where clusters of KIF5B were observed (Figure 7A).
High magnification of the future branching points showed
co-localization of mitochondria and KIF5B in the absence or
low levels of b-III-tubulin (Figure 7B). It is worth noting the
lack of KIF5B accumulation in dendritic growth cones when
compared with axonal growth cones (Figure 7B). This is most
likely to be the result of differences in the polarity of the
microtubules, with axonal microtubules uniformly oriented
with their plus-ends distal to the cell body and dendritic
microtubules displaying a mixture of plus-end and minus-end
orientations (Heidemann, 1996; Baas, 2002), as KIF5B
Figure 6 Reorganization of microtubules and corresponding microtubule-binding proteins in PC12-ND6 cells
(A) Stage-specific redistribution of MAP-1A. PC12-ND6 cells were labelled with anti-b-III-tubulin antibody (red), anti-MAP-1A
antibody (green) and TO-PROH-3 (blue). In stage II PC12-ND6 cells (top row), MAP-1A is evenly distributed throughout the cell. In
stage III PC12-ND6 cells (bottom row), a MAP-1A gradient has been established with MAP-1A labelling excluded from the nascent
axon, as indicated by white arrows. Scale bar, 10 mm. (B) Stage-specific redistribution of MAP-2. PC12-ND6 cells were labelled with
anti-b-III-tubulin antibody (red), anti-MAP-2 antibody (green) and TO-PROH-3 (blue). In stage II PC12-ND6 cells (top row), MAP-2 is
evenly distributed throughout the cell. In stage III PC12-ND6 cells (bottom row), a gradient of MAP-2 has been established, with
MAP-2 labelling excluded from the growing axon (white arrows), but present within developing dendrites (white arrowhead). Scale
bar, 10 mm. (C) Total tau is evenly distributed in PC12-ND6 cells at stages II and III. PC12-ND6 cells were labelled with anti-b-III-
tubulin antibody (red), an antibody recognizing all forms of tau (total tau, green) and TO-PROH-3 (blue). Scale bar, 10 mm. (D)
Expression of unphosphorylated tau is enriched in the distal portion of growing axons in stage III PC12-ND6 cells. PC12-ND6 cells
were labelled with anti-b-III-tubulin antibody (red), antibody recognizing only the unphosphorylated form of tau (Un-P Tau, green)
and TO-PROH-3 (blue). In stage II PC12-ND6 cells (top row), unphosphorylated tau is evenly distributed throughout the soma and
neurites. In contrast, stage III PC12-ND6 cells (bottom row) display unphosphorylated tau enriched within the distal portion of the
growing axon, as indicated by arrows. Scale bar, 10 mm.
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together, our results provide the first demonstration that
NeuroD6 promotes proper mitochondrial subcellular distri-
bution through the expression and appropriate stage-specific
redistribution of key cytoskeletal elements, cytoskeletal-
associated proteins and the motor protein KIF5B during the
early stages of neuronal differentiation.
Depolymerization of the actin or microtubule
network results in decreased mitochondrial area
despite constitutive NeuroD6 expression
We next asked the question of whether NeuroD6-mediated
increase in mitochondrial mass could be sustained upon
depolymerization of the actin or microtubule network. Since
the microtubule and actin networks have distinct functions in
mitochondrial trafficking (Morris and Hollenbeck, 1995; Ligon
and Steward, 2000a; Chada and Hollenbeck, 2004), we
elected to disrupt each cytoskeletal component separately
using either nocodazole to disrupt the microtubule network
or latrunculin B to inhibit actin polymerization. PC12-ND6
cells were treated with 10 mg/ml nocodazole or 15 mM
latrunculin B for 10 h, followed by a 30-h-long recovery
period, during which we monitored the integrity of actin or
microtubule network in conjunction with mitochondrial area,
as described in the Materials and methods section.
As expected, incubation with nocodazole or latrunculin B
led to substantial retraction of neuritic processes, resulting in
decreased frequency of stage II and III PC12-ND6 cells, while
vehicle (DMSO)-only treated PC12-ND6 cells retained their
original frequency (see Supplementary Figure S3A at http://
asnneuro.org/an/001/an001e016.add.htm). The immunohisto-
chemistry results confirmed that nocodazole treatment
selectively disrupted the microtubule network and latrunculin
B selectively depolarized actin filaments (see Supplementary
Figures S3B and S3C). Disruption of the actin or microtubule
network had a severe impact on the mitochondrial area of
treated PC12-ND6 cells, as compared with vehicle-only
treated PC12-ND6 cells. Interestingly, it differentially affec-
ted the distribution pattern of mitochondria, with latrunculin
B-treated PC12-ND6 cells displaying mitochondria essentially
aggregated around the MTOC (microtubule-organizing cen-
tre) (see Supplementary Figure S3B) and nocodazole-treated
PC12-ND6 cells harbouring mitochondria evenly localized to
the perinuclear region (see Supplementary Figure S3C).
Figure 7 Subcellular distribution of the motor protein KIF5B and mitochondria in PC12-ND6 cells at distinct stages of neuronal
differentiation
(A) Mitochondria, KIF5B and tubulin closely overlap throughout the early stages of neuronal differentiation. PC12-ND6 cells were
labelled with MTR and antibodies against KIF5B (green) and b-III-tubulin (blue). Scale bar, 10 mm. (B) Co-localization of KIF5B and
mitochondria within growth cones and branching points. High-magnification images of the boxed regions reveal that mitochondria
are located in axonal (a) and dendritic (d) growth cones (gc), whereas KIF5B protein is detected at the leading edge of the growth
cones. Mitochondria also accumulate in the branching points (bp) of growing processes. Scale bar, 5 mm.
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205We next investigated whether the decline in mitochondrial
content was reversible upon re-establishment of proper
cytoskeletal reorganization by switching to drug-free med-
ium over a period of 30 h. PC12-ND6 cells regained their
original morphology, characteristic of stages II and II within a
30-h period, with mitochondrial area being restored to
original levels in a time-dependent manner peaking after a
15-h-long recovery (see Supplementary Figures S3B–S3D).
Although phalloidin and a-tubulin labelling revealed recovery
of the microtubule and actin networks within the first 2 h
following drug removal, recovery of mitochondrial content
was significantly delayed, with partial restoration of the
mitochondrial compartment after 6 h of recovery, which was
stably maintained after 30 h, suggesting that the observed
decrease in mitochondrial content was not a by-product of
cytotoxicity from nocodazole or latrunculin B exposure, but
was most likely to be due to disruption of the cytoskeletal
architecture (see Supplementary Figure S3D).
DISCUSSION
In the present paper, we report a novel role for NeuroD6 in
increasing mitochondrial mass. First, we have demonstrated
that the increase in mitochondrial mass occurs during the
very first step of neuronal differentiation, the lamellipodia
stage I, thus preceding neurite outgrowth. Secondly, we have
shown that NeuroD6 concurrently co-ordinates mitochon-
drial mass increase with cytoskeletal remodelling, resulting in
mitochondrial distribution in developing neuronal processes
with accumulation in growth cones (Figure 8). Thirdly, such
co-ordination is required to sustain mitochondrial mass
during neuronal differentiation. Thus the present study
provides the first evidence of a neurogenic-specific regu-
lation of mitochondrial mass in the context of neuronal
differentiation, as most studies have essentially revealed
ubiquitously expressed transcription factors modulating
mitochondrial biogenesis in the context of physiological
adaptations and differentiation of cellular systems, such as
adipocytes and muscle cells.
The lack of a suitable cellular paradigm and/or animal
models has hampered studies on mitochondrial biogenesis at
the early stages of neurogenesis. Knockout of key transcrip-
tional regulators for mitochondrial biogenesis, such as the
mitochondrial-specific polymerase c PolG and Tfam, results in
early embryonic lethality, at E8.5 (Hance et al., 2005) and
E10.5 (Larsson et al., 1998) respectively. Although cultured
embryonic E18 hippocampal neurons are widely used to
investigate the mechanisms regulating mitochondrial traf-
ficking, they are not amenable to investigate mitochondrial
biogenesis and its neuronal regulators during the early stages
of neuronal differentiation, since the first three stages occur
within an extremely narrow timeframe of 36 h after plating
(Dotti et al., 1988).
Given the ability of NeuroD6 to promote neuritogenesis via
increased expression of cytoskeletal genes (Uittenbogaard
and Chiaramello, 2002, 2004; Uittenbogaard et al., 2009) and
the recently identified NeuroD6 target gene, PRG-1, also
called plasticity-related gene-1, a member of the LPP (lipid
phosphate phosphatase) family facilitating axonal elongation
Figure 8 Working model of NeuroD6-mediated co-ordination of mitochondrial mass with cytoskeletal rearrangement in PC12-ND6
cells
NeuroD6 induces cytoskeletal remodelling, appropriate stage-specific redistribution of MAP-1A and MAP-2, as well as a gradient of
unphosphorylated tau in developing processes of stage III PC12-ND6 cells, which facilitate efficient binding of KIF5B with
mitochondria in the proximal portion of the developing axon and the release of KIF5B with its cargo at the distal portion of the
developing axon.
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2008; Yamada et al., 2008), the PC12-ND6 cells sponta-
neously recapitulate the first four stages of neuronal
differentiation, thus providing a limitless source of differ-
entiating neuronal cells, making them an instructive in vitro
neuronal system to investigate mitochondrial biogenesis and
its transcriptional regulation. Furthermore, the PC12-ND6
cellular paradigm allows investigating the intrinsic properties
of NeuroD6, independently of any extrinsic differentiation
signalling and the functional redundancy between members
of the NeuroD family. Since the untreated PC12 cells share
characteristics with neuroprogenitors (Leonard et al., 1987;
Greene et al., 1998; Angelastro et al., 2000, 2002), our current
experimental paradigm has enabled us to investigate the
dynamic modulation of mitochondrial mass during the early
stages of transition between neuroprogenitor-like cells to
differentiating neuronal cells. Therefore it is an advantageous
in vitro cellular system to initiate studies of the transcription
pathways controlling mitochondrial biogenesis at the outset
of neuronal differentiation, which can then be tested further
in more challenging in vivo systems. However, the PC12-ND6
cellular paradigm has inherent limitations, such as the lack of
diversity in terms of lineages and response to diverse
signalling pathways, which prevent addressing the question
of how mitochondrial biogenesis is tailored to specific needs
of neuronal populations upon cell fate commitment and
differentiation.
Using a combination of flow cytometry, confocal micro-
scopy and mitochondrial protein fractionation, we have
demonstrated that constitutive expression of NeuroD6 results
in increased mitochondrial content, coinciding with cyto-
plasmic expansion associated with the lamellipodia forma-
tion. Although the overall cell volume of PC12-ND6 cells is
greater than that of the progenitor-like PC12 cells, the results
of mitochondrial protein fractionation normalized against
total protein content show a significant 3.66-fold increase in
mitochondrial content, even when taking into account the
increased cellular volume. Our findings are in keeping with
the emerging link between mitochondrial expansion and
spontaneous differentiation of mouse and human ESCs
(embryonic stem cells) (St John et al., 2005; Cho et al.,
2006). Undifferentiated and proliferative D3 mouse ESCs
contain few and immature mitochondria, whereas loss of ESC
pluripotency coupled with onset of cellular differentiation is
accompanied by a gradual increase in mtDNA (mitochondrial
DNA) replication (Facucho-Oliveira et al., 2007).
Whereas our results demonstrate that NeuroD6 increases
the mitochondrial content, the underlying mechanisms by
which NeuroD6 triggers mitochondrial biogenesis remain to
be elucidated. It could involve shifting the balance from
fusion to fission, increasing mtDNA replication, stimulating
the mitochondrial biogenic transcriptional cascade, diminish-
ing mitochondria turnover or any combination of these
regulatory pathways depending on the stage of neuronal
differentiation.
Since mitochondrial biogenesis is not suspected to occur de
novo (Detmer and Chan, 2007), an increase in mitochondrial
mass may in part result from increased rate of mitochondrial
fission at the expense of fusion (Nunnari et al., 1997; Mozdy
and Shaw, 2003; Scott et al., 2003; Karbowski and Youle,
2003). Mitochondrial fission is mediated by three proteins,
Fis1, Drp-1/DLP1/Dmn1 and the recently identified Mff
protein (Mozdy et al., 2000; Jakobs et al., 2003; James et al.,
2003; Yoon et al., 2003; Schauss et al., 2006; Gandre-Babbe
and van der Bliek, 2008), whereas mitochondrial fusion is
under the control of the Mitofusin-1 and -2 proteins (Mfn1
and Mfn2), and the optic atrophy-1 protein (OPA1) (Santel
and Fuller, 2001; Olichon et al., 2002; Ishihara et al., 2003;
Satoh et al., 2003; Cerveny et al., 2007). Future studies are
required to directly assess the link between NeuroD6
expression and the rate of fusion and fission using a
mitochondrial matrix-targeted photoactivable green fluor-
escent protein (Patterson and Lippincott-Schwartz, 2002;
Karbowski et al., 2004).
The fact that NeuroD6 increases the expression of
mitochondrial-related genes, involved in several aspects of
mitochondrial function,includingmitochondrial bioenergetics,
proteinfoldingand oxidativemetabolism (Uittenbogaardet al.,
2009), strongly supports the notion of NeuroD6 promoting
mitochondrial biogenesis. It is conceivable that NeuroD6 may
regulate the mitochondrial biogenic transcriptional pathway
to stimulate mtDNA replication and transcription, via the well-
established regulator PGC-1a. Although the role of PGC-1a in
mitochondrial biogenesis has not been addressed in a neuronal
context, recent studies suggest a potential role in neuronal
function (Lin et al., 2004; Leone et al., 2005; Liang and Wong-
Riley, 2006; Cowell et al., 2007), which is in keeping with
increasedneuronalexpressionof NRF-1 and NRF-2,both under
PGC-1a control to promote the expression of nuclear- and
mitochondrial-encoded subunits of COX IV, essential for
mitochondrial biogenesis (Ongwijitwat and Wong-Riley,
2005; Ongwijitwat et al., 2006; Meng et al., 2007; Dhar and
Wong-Riley, 2009).
The finding that constitutive NeuroD6 expression is
sufficient to induce cytoskeletal remodelling has important
functional implications, since cytoskeleton plays a cardinal
role in both the morphological changes upon differentiation
from a precursor to a neuron and mitochondrial trafficking
(reviewed by Matus, 1988; Hollenbeck and Saxton, 2005). In
keeping with our previous findings of increased expression of
microtubules and MAPs (Uittenbogaard and Chiaramello,
2004), we showed that the actin and microtubule cytoske-
letons and their associated binding proteins are appropriately
remodelled in PC12-ND6 cells at each stage of neuronal
differentiation. Actin remodelling is particularly relevant, as
maximal increase in mitochondrial mass occurs at stage I,
during which the actin network is extensively remodelled for
lamellipodia and filopodia formation (reviewed by da Silva
and Dotti, 2002). This concerted action is critical, as
reorganization of actin filaments and microtubules must be
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207co-ordinated during neuritogenesis (reviewed by Dehmelt
and Halpain, 2004; Dent et al., 2007).
NeuroD6 by itself is sufficient to induce a gradient of
MAP-1A and MAP-2 expression as well as a proximo-distal
gradient of unphosphorylated tau, similar to that observed in
developing cultured hippocampal neurons, with MAP-1A and
MAP-2 predominantly expressed in the proximal segment of
nascent axons and enriched expression of unphosphorylated
tau (at the Tau-1 epitope) in the distal portion of developing
axons. Such gradients are critical not only to regulate
microtubule dynamics in developing axons and dendrites, but
also to promote mitochondrial transport, as microtubules
serve as tracks for anterograde mitochondrial trafficking
(Nangaku et al., 1994; Morris and Hollenbeck, 1995; Rickard
and Kreis, 1996) in conjunction with the motor protein KIF5B
(Cai et al., 2005, 2007; Hollenbeck and Saxton, 2005; Pilling
et al., 2006; Glater et al., 2006). MAPs inhibit kinesin- and
dynein-dependent mitochondrial movement along microtu-
bules, by competing for binding to the microtubule surface
(Ebneth et al., 1998; Trinczek et al., 1999; Seitz et al., 2002;
Mandelkow et al., 2003; Jimenez-Mateos et al., 2006). The
correlation between the proximo-distal gradient of phos-
phorylated tau, mitochondria labelling, and KIF5B pattern of
distribution in PC12-ND6 cells (Figure 8), is consistent with
the notion that phosphorylated tau permits anterograde
movement of mitochondria by allowing the binding of KIF5B
coupled to mitochondria on to microtubules (Doble and
Woodgett, 2003; Tatebayashi et al., 2004; Mazanetz and
Fischer, 2007). The preponderance of unphosphorylated tau in
the distal portion of the developing axons of stage III PC12-
ND6 cells would favour the release of KIF5B from
microtubules, resulting in increase of free (unbound) KIF5B
and dispersion of mitochondria, a mechanism that could
deliver mitochondria to regions with high-energy demands,
such as growth cones (Figure 8).
The fact that maximal increase in mitochondrial mass
coincides with lamellipodia formation adds support to the
notion that actin plays a critical role in local trafficking of
mitochondria. Although most mitochondrial movement in
neurons is microtubule-dependent (Ligon and Steward,
2000b), a growing body of evidence has highlighted actin-
based mitochondrial local transport in growth cones and
branching points, where microtubules are scarce (Morris and
Hollenbeck, 1995, Ligon and Steward, 2000a; Langford 2002;
Bridgman 2004; Hollenbeck and Saxton, 2005; Frederick and
Shaw, 2007). Actin filaments are also necessary for the NGF-
induced docking of mitochondria along axons of cultured
sympathetic neurons (Chada and Hollenbeck, 2003, 2004). In
the unicellular budding yeast system, proper mitochondrial
inheritance along the mother-bud axis is ensured by actin-
mediated motility (reviewed by Boldogh and Pon, 2006).
In conclusion, the present study documents for the first
time that the neurogenic transcription factor NeuroD6 co-
ordinates increase in mitochondrial mass concurrently with
cytoskeletal remodelling at the very early stages of neuronal
differentiation. Most importantly, our results shed some light
on the transcriptional cues controlling the delicate balance
between generating and maintaining the mitochondrial
biomass, which is tailored to meet the specific energetic
needs of differentiating neuronal cells. It is also conceivable
that defects in acquiring proper mitochondrial mass at the
outset of neural development may play a role in development
of neurodegenerative diseases later in life.
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